You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Authors' response
  1. Michael Georgopoulos,
  2. Kaija Polak,
  3. Franz Prager,
  4. Christian Prünte,
  5. Ursula Schmidt-Erfurth
  1. Department of Ophthalmology, Medical University of Vienna, Vienna, Austria
  1. Correspondence to Professor Dr Ursula Schmidt-Erfurth, Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria; ursula.schmidt-erfurth{at}meduniwien.ac.at

https://doi.org/10.1136/bjo.2009.166918

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We appreciate the interest of Muhammad Raja et al in our article and would like to thank them for their useful contribution. We read with interest their similar findings in one patient they have treated with bevacizumab (Avastin) who …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles